Neuropsychopharmacology reviews the principles of pharmacology with a focus on the central nervous system and autonomic nervous system. Beyond autonomic and central nervous system pharmacology, this volume uniquely discusses psychiatric disorders and the pharmacological interventions that are available for conditions including depression, schizophrenia and anxiety disorders. With a focus on these specific body systems, readers will see end-of-chapter questions that offer real-world case studies, as well as multiple-choice questions for further learning. Beneficial features and content also include two extensive examination tests, which each contain 100 questions for better learning or to be used in teaching, and a glossary.
Helpful appendices cover high-alert medications and toxicology effects on the nervous system. Each chapter will contain classifications of medications, pharmacokinetics, mechanism of action, clinical indications and toxicities.
1. Chapter 1. Introduction - p. 3 2. Chapter 2. Drug approval and drug regulations - p. 13 3. Chapter 3. Pharmacokinetics - p. 29 4. Chapter 4. Pharmacodynamics - p. 55 5. Chapter 5. Pharmacogenomics, drug toxicity, and environmental toxins - p. 75 6. Chapter 6. Medication errors and risk reduction - p. 97 7. Chapter 7. Substance abuse - p. 111 8. Chapter 8. Dietary supplements and herbal remedies - p. 129 9. Unit II: Pharmacology of the central nervous system - p. 150 10. Chapter 9. Review of the central nervous system - p. 153 11. Chapter 10. Opioid and nonopioid analgesics - p. 181 12. Chapter 11. Antiseizure drugs - p. 199 13. Chapter 12. Skeletal muscle relaxants - p. 215 14. Chapter 13. General anesthesia - p. 227 15. Chapter 14. Local anesthesia - p. 245 16. Chapter 15. Pharmacology of Parkinson's disease - p. 257 17. Chapter 16. Pharmacology of Alzheimer’s disease - p. 275 18. Chapter 17. Pharmacology of migraines - p. 287 19. Unit III: Introduction to autonomic pharmacology - p. 301 20. Chapter 18. Review of the autonomic nervous system - p. 305 21. Chapter 19. Adrenergic agonists - p. 319 22. Chapter 20. Adrenergic antagonists - p. 335 23. Chapter 21. Cholinergic agonists - p. 351 24. Chapter 22. Cholinergic antagonists - p. 363 25. Unit IV: Pharmacology of psychiatric disorders - p. 374 26. Chapter 23. Pharmacology of anxiety and sleep disorders - p. 379 27. Chapter 24. Pharmacology of depressive disorders - p. 407 28. Chapter 25. Pharmacology of bipolar disorder - p. 429 29. Chapter 26. Pharmacology of schizophrenia - p. 441 30. Chapter 27. Pharmacology for attention-deficit/hyperactivity disorder - p. 457 31. Chapter 28. Pharmacology of dissociative disorders - p. 471 32. Chapter 29. Pharmacology of personality disorders - p. 481 33. Chapter 30. Pharmacology of somatic symptom disorders - p. 497 34. Appendix A: list of high-alert medications - p. 511 35. Appendix B: Toxicology effects on the nervous system - p. 513 36. Appendix C: Answer key to clinical case studies - p. 515 37. Glossary - p. 541 38. Index - p. 559
Neuropsychopharmacology reviews the principles of pharmacology with a focus on the central nervous system and autonomic nervous system. Beyond autonomic and central nervous system pharmacology, this volume uniquely discusses psychiatric disorders and the pharmacological interventions that are available for conditions including depression, schizophrenia and anxiety disorders. With a focus on these specific body systems, readers will see end-of-chapter questions that offer real-world case studies, as well as multiple-choice questions for further learning. Beneficial features and content also include two extensive examination tests, which each contain 100 questions for better learning or to be used in teaching, and a glossary.
Helpful appendices cover high-alert medications and toxicology effects on the nervous system. Each chapter will contain classifications of medications, pharmacokinetics, mechanism of action, clinical indications and toxicities.
1. Chapter 1. Introduction - p. 3 2. Chapter 2. Drug approval and drug regulations - p. 13 3. Chapter 3. Pharmacokinetics - p. 29 4. Chapter 4. Pharmacodynamics - p. 55 5. Chapter 5. Pharmacogenomics, drug toxicity, and environmental toxins - p. 75 6. Chapter 6. Medication errors and risk reduction - p. 97 7. Chapter 7. Substance abuse - p. 111 8. Chapter 8. Dietary supplements and herbal remedies - p. 129 9. Unit II: Pharmacology of the central nervous system - p. 150 10. Chapter 9. Review of the central nervous system - p. 153 11. Chapter 10. Opioid and nonopioid analgesics - p. 181 12. Chapter 11. Antiseizure drugs - p. 199 13. Chapter 12. Skeletal muscle relaxants - p. 215 14. Chapter 13. General anesthesia - p. 227 15. Chapter 14. Local anesthesia - p. 245 16. Chapter 15. Pharmacology of Parkinson's disease - p. 257 17. Chapter 16. Pharmacology of Alzheimer’s disease - p. 275 18. Chapter 17. Pharmacology of migraines - p. 287 19. Unit III: Introduction to autonomic pharmacology - p. 301 20. Chapter 18. Review of the autonomic nervous system - p. 305 21. Chapter 19. Adrenergic agonists - p. 319 22. Chapter 20. Adrenergic antagonists - p. 335 23. Chapter 21. Cholinergic agonists - p. 351 24. Chapter 22. Cholinergic antagonists - p. 363 25. Unit IV: Pharmacology of psychiatric disorders - p. 374 26. Chapter 23. Pharmacology of anxiety and sleep disorders - p. 379 27. Chapter 24. Pharmacology of depressive disorders - p. 407 28. Chapter 25. Pharmacology of bipolar disorder - p. 429 29. Chapter 26. Pharmacology of schizophrenia - p. 441 30. Chapter 27. Pharmacology for attention-deficit/hyperactivity disorder - p. 457 31. Chapter 28. Pharmacology of dissociative disorders - p. 471 32. Chapter 29. Pharmacology of personality disorders - p. 481 33. Chapter 30. Pharmacology of somatic symptom disorders - p. 497 34. Appendix A: list of high-alert medications - p. 511 35. Appendix B: Toxicology effects on the nervous system - p. 513 36. Appendix C: Answer key to clinical case studies - p. 515 37. Glossary - p. 541 38. Index - p. 559
